Skip to main content

Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens.

H9N2 subtype avian influenza virus of low pathogenicity (LPAIV) are distributed worldwide and cause enormous economic losses in the poultry industry. Although almost all the chickens immunized with the inactivated vaccine, the disease is still widespread. We speculate that increase mucosal or cellular immune response may contribute to improving the H9N2 virus surveillance. 

In this study, we Bovine Recombinant Proteins constructed a novel Lactococcus lactis (L. lactis) strain expressing a recombinant fusion protein consisting of the M1 and HA2 proteins derived from the H9N2 viral strain endemic conserved antigens. M1-HA2 fusion protein was cloned downstream of the gene encoding the secretory peptide, and we subsequently confirmed that the fusion protein is secreted from L. 

lactis by Western blotting. We assess the immunogenicity and protective effects of recombinant L. lactis this tension. Eight chicken 1-day-old were divided into four groups, and the experimental group orally vaccinated twice with recombinant L. lactis strain. fecal and intestinal samples, sera and bronchoalveolar lavage fluid was collected at 7, 14 and 21 days post-vaccination (DPV). 

Chickens vaccinated with a recombinant L. lactis strains showed significantly increase the levels of serum antibodies, T cell-mediated immune responses, and mucosal secretory IgA (SIgA). Following challenge with H9N2 virus in 21 DPV, chickens vaccinated with the recombinant L. lactis strains showed weight loss, lowering viral titers in the lungs, and reduce the pathological damage lungs.
Recombinant Lactococcus Lactis Expressing M1-HA2 Fusion Protein Provides Protective Mucosal Immunity Against H9N2 Avian Influenza Virus in Chickens.


 In summary, our results suggest that Cat Recombinant Proteins recombinant L. lactis strain H9N2 M1-HA2 express the fusion protein can induce a protective mucosal and systemic immunity. The oral vaccine is the H9N2 virus-specific and is a significant design improvement compared with previous studies. Our study provides a theoretical basis for improving mucosal immune responses to prevent and control the H9N2 virus infection.
Labels:

Comments

Post a Comment

Popular posts from this blog

Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein.

Human norovirus (HuNoV) is responsible for over 95% of outbreaks of acute nonbacterial gastroenteritis worldwide. Despite great efforts, there is no vaccine or effective therapeutic intervention against this virus. Chicken immunoglobulin Y (IgY) based passive immunization has proven to be an effective strategy for preventing and treating many diseases enteric viruses. Here, we develop highly efficient bioreactor Parasite Recombinant Proteins  to produce high titers of specific HuNoV yellow chicken IgY in using recombinant vesicular stomatitis virus expressing HuNoV capsid protein (rVSV-VP1) as antigen. We first show that HuNoV VP1 protein is highly expressed in chicken cells infected with rVSV-VP1.  Furthermore, we find that the White Leghorn chickens were immunized intramuscularly with rVSV-VP1 high level trigger specific HuNoV yolk antibody IgY. yellow efficiently purified IgY recognized by HuNoV virus-like particle (VLP). Importantly, specific IgY efficient HuNoV HuNoV blo...
Post a Comment
Read more

Expression and serological application of recombinant epitope-repeat protein carrying an immunodominant epitope of Newcastle disease virus nucleoprotein.

The purpose of this study was to develop serodiagnostic test for differentiation of infected from vaccinated animals strategy (DIVA) which accompanies a marker vaccine less immunodominant epitope (IDE) from the nucleoprotein of Newcastle disease virus (NDV) .Recombinant epitope-repeat protein (rERP) genes that encode eight IDE sequence repeats (ETQFLDLMRAVANSMR) by tetra-glycine linker was synthesized.  Recombinant baculovirus carrying the gene Canine Recombinant Proteins  for expressing rERP rERP produced in insect cells. Specificity and sensitivity enzyme-linked immunosorbent assay indirect (ELISA) employing rERP is evaluated The rERP with a molecular weight of 20 kDa successfully expressed by recombinant baculovirus in an insect-baculovirus system. The rERP is functional antigen as shown by Western blotting. ELISA indirectly employs rERP developed and specificity and sensitivity is determined. ELISA test allows discrimination of NDV-infected sera from vaccinated deletion v...
Post a Comment
Read more